| Literature DB >> 29031087 |
Tobey J Betthauser1, Paul A Ellison2, Dhanabalan Murali2, Patrick J Lao3, Todd E Barnhart2, Shozo Furumoto4, Nobuyuki Okamura5, Sterling C Johnson6, Jonathan W Engle2, Robert J Nickles2, Bradley T Christian3.
Abstract
This work characterizes the radiochemical synthesis, purification, and formulation of [18F]THK-5351, a tau PET radioligand, and develops an automated radiosynthesis routine (ELIXYS, Sofie Biosciences). Nucleophilic radiofluorination reaction was complete by 7min at 110°C with radiochemical yields proportional to precursor mass (0.1-0.5mg). Optimized HPLC purification produced radiotracer product with no chemical impurities observed on analytical HPLC in formulation. Automated radiosynthesis (ELIXYS), HPLC purification and formulation was completed in 86min producing formulated product suitable for human research use.Entities:
Keywords: Alzheimer's disease; Automation; Formulation; Positron emission tomography; Radiochemical stability; Radiochemistry; THK; USP
Mesh:
Substances:
Year: 2017 PMID: 29031087 PMCID: PMC5673567 DOI: 10.1016/j.apradiso.2017.10.002
Source DB: PubMed Journal: Appl Radiat Isot ISSN: 0969-8043 Impact factor: 1.513